426 related articles for article (PubMed ID: 12115238)
1. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.
Hoffman GS; Cid MC; Hellmann DB; Guillevin L; Stone JH; Schousboe J; Cohen P; Calabrese LH; Dickler H; Merkel PA; Fortin P; Flynn JA; Locker GA; Easley KA; Schned E; Hunder GG; Sneller MC; Tuggle C; Swanson H; Hernández-Rodríguez J; Lopez-Soto A; Bork D; Hoffman DB; Kalunian K; Klashman D; Wilke WS; Scheetz RJ; Mandell BF; Fessler BJ; Kosmorsky G; Prayson R; Luqmani RA; Nuki G; McRorie E; Sherrer Y; Baca S; Walsh B; Ferland D; Soubrier M; Choi HK; Gross W; Segal AM; Ludivico C; Puechal X;
Arthritis Rheum; 2002 May; 46(5):1309-18. PubMed ID: 12115238
[TBL] [Abstract][Full Text] [Related]
2. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
van der Veen MJ; Dinant HJ; van Booma-Frankfort C; van Albada-Kuipers GA; Bijlsma JW
Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437
[TBL] [Abstract][Full Text] [Related]
3. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).
Spiera RF; Mitnick HJ; Kupersmith M; Richmond M; Spiera H; Peterson MG; Paget SA
Clin Exp Rheumatol; 2001; 19(5):495-501. PubMed ID: 11579707
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.
Mahr AD; Jover JA; Spiera RF; Hernández-García C; Fernández-Gutiérrez B; Lavalley MP; Merkel PA
Arthritis Rheum; 2007 Aug; 56(8):2789-97. PubMed ID: 17665429
[TBL] [Abstract][Full Text] [Related]
5. The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study.
Kreis L; Dejaco C; Schmidt WA; Németh R; Venhoff N; Schäfer VS
Trials; 2024 Jan; 25(1):56. PubMed ID: 38225579
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.
Koster MJ; Yeruva K; Crowson CS; Muratore F; Labarca C; Warrington KJ
J Rheumatol; 2019 May; 46(5):501-508. PubMed ID: 30647171
[TBL] [Abstract][Full Text] [Related]
7. Treatment with methotrexate and risk of relapses in patients with giant cell arteritis in clinical practice.
Leon L; Rodriguez-Rodriguez L; Morado I; Rosales Z; Vadillo C; Freites D; Macarron P; Fernandez-Gutierrez B; Blanco M; Jover JA; Abasolo L
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):121-128. PubMed ID: 29303708
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.
Jover JA; Hernández-García C; Morado IC; Vargas E; Bañares A; Fernández-Gutiérrez B
Ann Intern Med; 2001 Jan; 134(2):106-14. PubMed ID: 11177313
[TBL] [Abstract][Full Text] [Related]
9. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
10. Effect of combined treatment with prednisone and methotrexate versus prednisone alone over laboratory parameters in giant cell arteritis.
Perez-Sancristobal I; Alvarez-Hernandez P; Lajas-Petisco C; Fernandez-Gutierrez B
Reumatol Clin (Engl Ed); 2024 Feb; 20(2):108-112. PubMed ID: 38395494
[TBL] [Abstract][Full Text] [Related]
11. [Management of polymyalgia rheumatica and large vessel vasculitis].
Hellmich B
Internist (Berl); 2016 Nov; 57(11):1069-1078. PubMed ID: 27631531
[TBL] [Abstract][Full Text] [Related]
12. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
13. Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.
Kermani TA; Warrington KJ; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; McAlear CA; Monach PA; Seo P; Merkel PA; Ytterberg SR;
J Rheumatol; 2015 Jul; 42(7):1213-7. PubMed ID: 25877501
[TBL] [Abstract][Full Text] [Related]
14. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.
Caporali R; Cimmino MA; Ferraccioli G; Gerli R; Klersy C; Salvarani C; Montecucco C;
Ann Intern Med; 2004 Oct; 141(7):493-500. PubMed ID: 15466766
[TBL] [Abstract][Full Text] [Related]
15. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
[TBL] [Abstract][Full Text] [Related]
16. A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.
Langford CA; Cuthbertson D; Ytterberg SR; Khalidi N; Monach PA; Carette S; Seo P; Moreland LW; Weisman M; Koening CL; Sreih AG; Spiera R; McAlear CA; Warrington KJ; Pagnoux C; McKinnon K; Forbess LJ; Hoffman GS; Borchin R; Krischer JP; Merkel PA;
Arthritis Rheumatol; 2017 Apr; 69(4):837-845. PubMed ID: 28133925
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate for treating polymyalgia rheumatica: A meta-analysis of randomized controlled trials.
Song GG; Lee YH
Int J Clin Pharmacol Ther; 2021 May; 59(5):366-371. PubMed ID: 33480843
[TBL] [Abstract][Full Text] [Related]
18. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.
Martínez-Taboada VM; Rodríguez-Valverde V; Carreño L; López-Longo J; Figueroa M; Belzunegui J; Mola EM; Bonilla G
Ann Rheum Dis; 2008 May; 67(5):625-30. PubMed ID: 18086726
[TBL] [Abstract][Full Text] [Related]
19. Giant cell arteritis in Mexican patients.
Alba MA; Mena-Madrazo JA; Reyes E; Flores-Suárez LF
J Clin Rheumatol; 2012 Jan; 18(1):1-7. PubMed ID: 22157266
[TBL] [Abstract][Full Text] [Related]
20. PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial.
Marsman DE; Bolhuis TE; den Broeder N; den Broeder AA; van der Maas A
Trials; 2022 Apr; 23(1):318. PubMed ID: 35428320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
